Non-malignant neutropenia

Blood Reviews

Volumn 10, Issue 2, 1996, Pages 95-100

  Sievers, E L ^a,b   Dale, D C ^b,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; ANTITHYROID AGENT; AUTOANTIBODY; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CHLORAMPHENICOL; CHLORPROMAZINE; GOLD; LEVAMISOLE; PARACETAMOL; PENICILLAMINE; PENICILLIN G; PHENOTHIAZINE DERIVATIVE; PHENYLBUTAZONE; PROPYLTHIOURACIL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SEDATIVE AGENT; SULFONAMIDE; TRANQUILIZER;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; AUTOIMMUNITY; BONE MARROW; CANCER RISK; CLINICAL TRIAL; ETIOLOGY; FELTY SYNDROME; HEMATOPOIETIC STEM CELL; HUMAN; INFECTION; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030037116     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(96)90038-7     Document Type: Article

References (42)

1. Karayalcin G, Rosner F, Sawitsky A. Pseudo-neutropenia in American Negroes. Lancet 1972; 1(746): 387.
2. Levine DH, Madyastha PR. Isoimmune neonatal neutropenia. Am J Perinatol 1986; 3(3): 231-233.
3. Bux J, Jung KD, Kauth T, Mueller-Eckhardt C. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia. Transfus Med 1992; 2(2): 143-149.
4. Stroncek DF, Skubitz KM, Plachta LB et al. Alloimmune neonatal neutropenia due to an antibody to the neutrophil Fc-gamma receptor III with maternal deficiency of CD 16 antigen. Blood 1991; 77(7): 1572-1580.
5. Shastri KA, Logue GL. Autoimmune neutropenia. Blood 1993; 81(8): 1984-1995.
6. Bussel JB, Abboud MR. Autoimmune neutropenia of childhood. Crit Rev Oncol Hematol 1987; 7(1): 37-51.
7. Bux J, Kissel K, Nowak K, Spengel U, Mueller-Eckhardt C. Autoimmune neutropenia: clinical and laboratory studies in 143 patients. Ann Hematol 1991; 63(5): 249-252.
8. Hartman KR, LaRussa VF, Rothwell SW, Atolagbe TO, Ward FT, Klipple G. Antibodies to myeloid precursor cells in autoimmune neutropenia. Blood 1994; 84(2): 625-631.
9. Neglia JP, Watterson J, Clay M et al. Autoimmune neutropenia of infancy and early childhood. Pediatr Hematol Oncol 1993; 10(4): 369-376.
10. Schiphorst PP, de Pauw BE. Autoimmune neutropenia successfully treated with cyclosporine. Ann Hematol 1995; 70(4): 223-225.
11. Storek J, Glaspy JA, Grody WW, Susi E, Slater ED. Adult-onset cyclic neutropenia responsive to cyclosporine therapy in a patient with ankylosing spondylitis. Am J Hematol 1993; 43(2): 139-143.
12. Goldberg J, Pinals RS. Felty syndrome. Semin Arthritis Rheum 1980; 10(1): 52-65.
13. Joyce RA, Boggs DR, Chervenick PA, Lalezari P. Neutr phil kinetics in Felty's syndrome. Am J Med 1980; 69(5): 695-702.
14. Stroncek DF. Drug-induced immune neutropenia. Transfus Med Rev 1993; 7(4): 268-274.
15. Dale D. Neutropenia. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams' Hematology, 5th edn. New York: McGraw-Hill, 1995: 815-824.
16. Dale DC, Guerry Dt, Wewerka JR, Bull JM, Chusid MJ. Chronic neutropenia. Medicine 1979; 58(2): 128-144.
17. Weetman RM, Boxer LA. Childhood neutropenia. Pediatr Clin North Am 1980; 27(2): 361-376.
18. Kostmann R. Infantile genetic agranulocytosis. A review with presentation of ten new cases. Acta Paediatr Scand 1975; 64(2): 362-368.
19. Parmley RT, Ogawa M, Darby CP Jr, Spicer SS. Congenital neutropenia: neutrophil proliferation with abnormal maturation. Blood 1975; 46(5): 723-734.
20. Wriedt K, Kauder E, Mauer AM. Defective myelopoiesis in congenital neutropenia. N Engl J Med 1970; 283(20): 1072-1077.
21. Bonilla MA, Gillio AP, Ruggeiro M et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989; 320(24): 1574-1580.
22. Pietsch T, Buhrer C, Mempel K et al. Blood mononuclear cells from patients with severe congenital neutropenia are capable of producing granulocyte colony-stimulating factor. Blood 1991; 77(6): 1234-1237.
23. Mempel K, Pietsch T, Menzel T, Zeidler C, Weite K. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 1991; 77(9): 1919-1922.
24. Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia [see comments]. N Engl J Med 1995; 333(8): 487-493.
25. Souid AK. Congenital cyclic neutropenia. Clin Pediatr 1995; 34(3): 151-155. 7
26. Dale DC, Hammond WP. Cyclic neutropenia: a clinical review. Blood Rev 1988; 2: 178-185.
27. Pincus SH, Boxer LA, Stossel TP. Chronic neutropenia in childhood. Analysis of 16 cases and a review of the literature. Am J Med 1976; 61(6): 849-861.
28. Jonsson OG, Buchanan GR. Chronic neutropenia during childhood. A 13-year experience in a single institution. Am J Dis Child 1991; 145(2): 232-235.
29. Jakubowski AA, Souza L, Kelly F et al. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med 1989; 320(1): 38-42.
30. Sonoda Y, Yashige H, Fujii H, Maekawa T. Abe T. Treatment of idiopathic neutropenia in the elderly with recombinant human granulocyte colony-stimulating factor. Acta Haematol 1991; 85(3): 146-152.
31. Saunders EF, Gall G, Freedman MH. Granulopoiesis in Shwachman's syndrome (pancreatic insufficiency and bone marrow dysfunction). Pediatrics 1979; 64(4): 515-519.
32. Huijgens PC, van der Veen EA, Meijer S, Muntinghe OG. Syndrome of Shwachman and leukaemia. Scand J Haem 1977; 18(1): 20-24.
33. Woods WG, Roloff JS, Lukens JN, Krivit W. The occurrence of leukemia in patients with the Shwachman syndrome. J Pediatr 1981; 99(3): 425-428.
34. O'Regan S, Newman AJ, Graham RC. 'Myelokathexis'. Neutropenia with marrow hyperplasia. Am J Dis Child 1977; 131(6): 655-658.
35. Roper M, Parmley RT, Crist WM, Kelly DR, Cooper MD. Severe congenital leukopenia (reticular dysgenesis). Immunologic and morphologic characterizations of leukocytes. Am J Dis Child 1985; 139(8): 832-835.
36. Levinsky RJ, Tiedeman K. Successful bone-marrow transplantation for reticular dysgenesis. Lancet 1983; 1(8326 Pt 1): 671-672.
37. Fischer A, Griscelli C, Friedrich W et al. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985. Lancet 1986; 2(8515): 1080-1084.
38. Dale DC, Bonilla MA, Davis MW et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81(10): 2496-2502.
39. Bonilla MA, Dale D, Zeidler C et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 1994; 88(4): 723-730.
40. Gilman PA, Jackson DP, Guild HG. Congenital agranulocytosis: prolonged survival and terminal acute leukemia. Blood 1970; 36(5): 576-585.
41. Rosen RB, Kang SJ. Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J Pediatr 1979; 94(3): 406-408.
42. Dale DC. Hematopoietic growth factors for the treatment of severe chronic neutropenia. Stem Cells 1995; 13(2): 94-100.